Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in up to Seven Different Tumor Types and in Diabetes for BMF-219

NEXT STORY
NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021
PREV STORY
Next Generation Sequencing Market Research Report by Type, by Technology, by Application, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mereo BioPharma to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference

author_avatar
NASDAQ Market News

BriaCell Adds New Clinical Site To Phase IIa Study in Advanced Breast Cancer and Expands R&D Team

The addition of the Cancer Center of Kansas (CCK) as a new clinical trial ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Top-line Data from Fixed Dose Portion of Phase 2 Trial Demonstrating Potential of TransCon™ PTH as a Replacement Therapy for Hypoparathyroidism

author_avatar
NASDAQ Market News